These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 453473)

  • 1. Hypercalcemia and malignant melanoma.
    Burt ME; Brennan MF
    Am J Surg; 1979 Jun; 137(6):790-4. PubMed ID: 453473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Melanoma and primary hyperparathyroidism].
    Maerens-Tchokokam B; Bailly N; Collet E; Dalac S; Rat P; Lambert D
    Ann Dermatol Venereol; 1993; 120(3):215-7. PubMed ID: 8239359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease.
    Benson RC; Riggs BL; Pickard BM; Arnaud CD
    Am J Med; 1974 Jun; 56(6):821-6. PubMed ID: 4831319
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypercalcaemia of melanoma: incidence, pathogenesis and therapy with bisphosphonates.
    des Grottes JM; Dumon JC; Body JJ
    Melanoma Res; 2001 Oct; 11(5):477-82. PubMed ID: 11595884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia in a patient with malignant melanoma arising in congenital giant pigmented nevus. A case of increased serum level of parathyroid hormone-related protein.
    Matsui T; Kageshita T; Ishihara T; Tomiguchi S; Takahashi M; Ono T
    Dermatology; 1998; 197(1):65-8. PubMed ID: 9693191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review.
    Attia P; Phan GQ; Duray PH; Rosenberg SA
    Am J Clin Oncol; 2003 Feb; 26(1):42-5. PubMed ID: 12576923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burn scar carcinoma and hypercalcemia.
    Gerner RE; Moore GE
    Ann Surg; 1974 Jul; 180(1):95-7. PubMed ID: 4835962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia due to parathyroid hormone-related protein secretion by melanoma.
    Yeung SC; Eton O; Burton DW; Deftos LJ; Vassilopoulou-Sellin R; Gagel RF
    Horm Res; 1998; 49(6):288-91. PubMed ID: 9623520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of procaine in acquired malignant hyperthermia in a patient with malignant melanoma metastatic to the parathyroid gland: a case report.
    Borden H; Hummer GJ; Landon CW; Paris J
    Can Anaesth Soc J; 1976 Nov; 23(6):616-23. PubMed ID: 990978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism.
    Parikshak M; Castillo ED; Conrad MF; Talpos GB
    Am Surg; 2003 May; 69(5):393-8; discussion 399. PubMed ID: 12769210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
    Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
    J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
    Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
    Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia in patients with known malignent disease.
    Samaan NA; Hickey RC; Sethi MR; Yang KP; Wallace S
    Surgery; 1976 Sep; 80(3):382-9. PubMed ID: 960005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary hyperparathyroidism. Current aspects of its diagnosis apropos of a case with digestive and neuropsychiatric manifestations].
    Sebert JL; Dupont A; Fournier A; Coevoet B; Lambrey G; Ghighi J; Quichaud J
    Sem Hop; 1978 Dec 18-25; 54(45-46):1488-93. PubMed ID: 219510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intestinal protein-losing syndrome in malignant melanoma with gastrointestinal tract involvement].
    Goebell H; Dombrowski H; Schmitz-Moormann P; Martini GA
    Internist (Berl); 1970 Apr; 11(4):142-5. PubMed ID: 4933144
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypercalcemia in thyrotoxicosis.
    Maxon HR; Apple DJ; Goldsmith RE
    Surg Gynecol Obstet; 1978 Nov; 147(5):694-6. PubMed ID: 715646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Hypercalcemia and carcinoma of the esophagus.
    Benrey J; Graham DY; Goyal RK
    Ann Intern Med; 1974 Mar; 80(3):415-6. PubMed ID: 4816189
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.
    Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE
    N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with the radioimmunoassay for parathyroid hormone in the diagnosis of primary hyperparathyroidism.
    Carswell GF; Anast CS; Thompson IM; Ross G
    Trans Am Assoc Genitourin Surg; 1977; 69():113-7. PubMed ID: 369090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.